Naringin attenuates renal interstitial fibrosis by regulating the TGF‑β/Smad signaling pathway and inflammation
Open Access
- 23 November 2020
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 21 (1) , 1
Abstract
Interstitial fibrosis is a typical feature of all progressive renal diseases. The process of fibrosis is frequently coupled with the presence of pro‑fibrotic factors and inflammation. Naringin is a dihydroflavone compound that has been previously reported to exhibit anti‑fibrotic effects in the liver, where it prevents oxidative damage. In the present study, a rat model of renal interstitial fibrosis and fibrosis cell model were established to evaluate the effects of naringin on inflammatory proteins and fibrosis markers in kidney of rats and NRK‑52E cells, and to elucidate the role of the TGF‑β/Smad signaling pathway in this mechanism. Compared with those in fibrotic NRK‑52E cells that were stimulated by transforming growth factor‑β (TGF‑β), gene expression levels of α‑smooth muscle actin (α‑SMA), collagen 1 (COL1A1), collagen 3 (COL3A1), interleukin (IL)‑1β, IL‑6 and tumor necrosis factor‑α (TNF‑α) were all found to be significantly decreased in fibrotic NRK‑52E cells following treatment with naringin (50, 100 and 200 ng/ml). Results from the histopathological studies showed that naringin treatment preserved the renal tissue structure and reduced the degree of fibrosis in the kidney tissues of rats that underwent unilateral ureteral obstruction (UUO). In addition, naringin administration reduced the expression of α‑SMA, COL1A1, COL3A1, IL‑1β, IL‑6 and TNF‑α in the kidneys of rats following UUO. The current study, using western blot analysis, indicated that naringin also downregulated the activation of Smad2/3 and the expression of Smad4, high‑mobility group protein B1, activator protein‑1, NF‑κB and cyclooxygenase‑2 whilst upregulating the expression of Smad7 in fibrotic NRK‑52E cells and rats in the UUO group. In conclusion, naringin could antagonize renal interstitial fibrosis by regulating the TGF‑β/Smad pathway and the expression of inflammatory factors.Keywords
This publication has 69 references indexed in Scilit:
- Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosisJournal of Clinical Investigation, 2013
- Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosisFrontiers in Endocrinology, 2013
- Charting the NF-κB Pathway Interactome MapPLOS ONE, 2012
- Toll-Like Receptor 4: A Novel Signaling Pathway During Renal FibrogenesisJournal of Surgical Research, 2011
- Chronic kidney disease growth factors in renal fibrosisClinical and Experimental Pharmacology and Physiology, 2011
- Activation of Toll-like receptor 9 attenuates unilateral ureteral obstruction-induced renal fibrosisActa Pharmacologica Sinica, 2010
- TLR4 Promotes Fibrosis but Attenuates Tubular Damage in Progressive Renal InjuryJournal of the American Society of Nephrology, 2010
- New insights into TGF-β–Smad signallingTrends in Biochemical Sciences, 2004
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001